Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions, An Issue of Interventional Cardiology Clinics
- 1st Edition, Volume 13-4 - September 12, 2024
- Editor: Luis Ortega Paz
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 6 7 2 - 7
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 6 7 3 - 4
In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy i… Read more
Purchase options
In this issue of Interventional Cardiology Clinics, guest editor Dr. Luis Ortega Paz brings his considerable expertise to the topic of Antiplatelet and Anticoagulation Therapy in Cardiovascular and Pulmonary Embolism Transcatheter Interventions. Top experts in the field discuss regulation of platelet activation and coagulation; genetic determinants of P2Y12 inhibitors and clinical implications; switching P2Y12 receptor inhibiting therapies; high bleeding risk in patients undergoing coronary and structural heart interventions; and much more.
- Contains 13 relevant, practice-oriented topics including antithrombotic therapy in atrial fibrillation patients undergoing coronary stenting; antithrombotic therapy in patients undergoing transcatheter aortic valve replacement; antithrombotic therapy in patients undergoing peripheral artery interventions; antiplatelet therapy in women; and more.
- Provides in-depth clinical reviews on antiplatelet and anticoagulation therapy in cardiovascular and pulmonary embolism transcatheter interventions, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Interventional Cardiologists
Regulation of Platelet Activation and Coagulation: Current Concepts, Novel Targets, and Therapies
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications
High Bleeding Risk in Patients Undergoing Coronary and Structural Heart Interventions
Antithrombotic Therapy in Patients with Chronic Coronary Syndromes
Antithrombotic Therapy in Acute Coronary Syndrome
Antithrombotic Therapy in Patients with Complex Percutaneous Coronary Intervention and Cardiogenic Shock
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention
Antithrombotic Therapy in Patients Undergoing Percutaneous Left Atrial Appendage Occlusion
Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions
Anticoagulant Therapy in Patients Undergoing Acute Pulmonary Embolism Interventions
Considerations in Antiplatelet Therapy in Women Undergoing Treatment of Acute Coronary Syndrome or Percutaneous Coronary Intervention
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications
High Bleeding Risk in Patients Undergoing Coronary and Structural Heart Interventions
Antithrombotic Therapy in Patients with Chronic Coronary Syndromes
Antithrombotic Therapy in Acute Coronary Syndrome
Antithrombotic Therapy in Patients with Complex Percutaneous Coronary Intervention and Cardiogenic Shock
Antiplatelet Therapy in Patients Requiring Oral Anticoagulation and Undergoing Percutaneous Coronary Intervention
Antithrombotic Therapy in Patients Undergoing Percutaneous Left Atrial Appendage Occlusion
Antithrombotic Therapy in Patients Undergoing Peripheral Artery Interventions
Anticoagulant Therapy in Patients Undergoing Acute Pulmonary Embolism Interventions
Considerations in Antiplatelet Therapy in Women Undergoing Treatment of Acute Coronary Syndrome or Percutaneous Coronary Intervention
- Edition: 1
- Volume: 13-4
- Published: September 12, 2024
- Language: English
LP
Luis Ortega Paz
Affiliations and expertise
Assistant Professor, Division of Cardiology, UF Health Cardiovascular Center, University of Florida College of Medicine-Jacksonvilley, FL, USA